Literature DB >> 30542487

Computed tomography and pathology evaluation of lung ground-glass opacity.

Hualong Yu1, Shihe Liu1, Chuanyu Zhang1, Shaoke Li1, Jianan Ren1, Jingli Zhang1, Wenjian Xu1.   

Abstract

The aim of this study was to investigate the pathogenesis of lung ground-glass opacity (GGO) and the diagnostic value of computed tomography scan for lung GGO. Computed tomography (CT) images of 106 lung GGO cases were analyzed retrospectively, and the type, location, size, structure, boundaries and surrounding lung fields were evaluated. There were 12 cases of GGO with a diameter <1.0 cm, 36 cases with diameter of 1.0-1.5 cm, 25 cases with diameter of 1.6-2.0 cm, 19 cases with diameter of 2.0-2.5 cm and 14 cases with diameter of 2.5-3.0 cm. There were 20 lesions with a round shape and 68 lesions with an oval shape. There were 56 lesions with spinous processes, 18 lesions with air bronchograms and 37 lesions with surrounding pleural indentation. The diagnosis and differential diagnosis of GGO would be improved with combined CT scan and pathology results.

Entities:  

Keywords:  X-ray; computed tomography; ground-glass opacity

Year:  2018        PMID: 30542487      PMCID: PMC6257275          DOI: 10.3892/etm.2018.6886

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  15 in total

1.  Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years.

Authors:  Ken Kodama; Masahiko Higashiyama; Hideoki Yokouchi; Koji Takami; Keiko Kuriyama; Yoko Kusunoki; Tomio Nakayama; Fumio Imamura
Journal:  Ann Thorac Surg       Date:  2002-02       Impact factor: 4.330

2.  Focal area of ground-glass opacity and ground-glass opacity predominance on thin-section CT: discrimination between neoplastic and non-neoplastic lesions.

Authors:  A Nambu; T Araki; Y Taguchi; K Ozawa; K Miyata; M Miyazawa; Y Hiejima; A Saito
Journal:  Clin Radiol       Date:  2005-09       Impact factor: 2.350

3.  Ground-glass opacity: high-resolution computed tomography and 64-multi-slice computed tomography findings comparison.

Authors:  Gianluigi Sergiacomi; Carmelo Cicciò; Luca Boi; Luca Velari; Sonia Crusco; Antonio Orlacchio; Giovanni Simonetti
Journal:  Eur J Radiol       Date:  2009-04-25       Impact factor: 3.528

4.  Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society.

Authors:  J H Austin; N L Müller; P J Friedman; D M Hansell; D P Naidich; M Remy-Jardin; W R Webb; E A Zerhouni
Journal:  Radiology       Date:  1996-08       Impact factor: 11.105

5.  Diagnostic value of computed tomography scanning in differentiating malignant from benign solitary pulmonary nodules: a meta-analysis.

Authors:  Chuan-Yu Zhang; Hua-Long Yu; Xia Li; Yong-Ye Sun
Journal:  Tumour Biol       Date:  2014-05-26

6.  Management of multiple pure ground-glass opacity lesions in patients with bronchioloalveolar carcinoma.

Authors:  Hong Kwan Kim; Yong Soo Choi; Jhingook Kim; Young Mog Shim; Kyung Soo Lee; Kwhanmien Kim
Journal:  J Thorac Oncol       Date:  2010-02       Impact factor: 15.609

7.  Correlation between computed tomographic findings, bronchioloalveolar carcinoma component, and biologic behavior of small-sized lung adenocarcinomas.

Authors:  Morihito Okada; Wataru Nishio; Toshihiko Sakamoto; Kazuya Uchino; Keisuke Hanioka; Chiho Ohbayashi; Noriaki Tsubota
Journal:  J Thorac Cardiovasc Surg       Date:  2004-03       Impact factor: 5.209

8.  Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer.

Authors:  Ryutaro Kakinuma; Hironobu Ohmatsu; Masahiro Kaneko; Masahiko Kusumoto; Junji Yoshida; Kanji Nagai; Yutaka Nishiwaki; Toshiaki Kobayashi; Ryosuke Tsuchiya; Hiroyuki Nishiyama; Eisuke Matsui; Kenji Eguchi; Noriyuki Moriyama
Journal:  J Comput Assist Tomogr       Date:  2004 Jan-Feb       Impact factor: 1.826

9.  The ratio of the maximum high attenuation area dimension to the maximum tumor dimension may be an index of the presence of lymph node metastasis in lung adenocarcinomas 3 cm or smaller on high-resolution computed tomography.

Authors:  Ryota Nishio; Soichi Akata; Kazuhiro Saito; Tatsuo Ohira; Masahiro Tsuboi; Takashi Hirano; Norihiko Ikeda; Fumio Kotake; Harubumi Kato; Kimihiko Abe
Journal:  J Thorac Oncol       Date:  2007-01       Impact factor: 15.609

10.  High incidence of EGFR mutations in pneumonic-type non-small cell lung cancer.

Authors:  Jun Liu; Jianfei Shen; Chenglin Yang; Ping He; Yubao Guan; Wenhua Liang; Jianxing He
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

View more
  5 in total

Review 1.  Considerations for the Surgical Management of Thoracic Cancers During the COVID-19 Pandemic: Rational Strategies for Thoracic Surgeons.

Authors:  Jiahao Zhang; Yichao Han; Yajie Zhang; Dong Dong; Yuqin Cao; Xiang Chen; Hecheng Li
Journal:  Front Surg       Date:  2022-05-09

Review 2.  From Radiological Manifestations to Pulmonary Pathogenesis of COVID-19: A Bench to Bedside Review.

Authors:  Amin Saburi; U Joseph Schoepf; Kyle A Ulversoy; Ramezan Jafari; Fatemeh Eghbal; Mostafa Ghanei
Journal:  Radiol Res Pract       Date:  2020-12-04

3.  Pixel-based analysis of pulmonary changes on CT lung images due to COVID-19 pneumonia.

Authors:  Elif Soya; Nur Ekenel; Recep Savas; Tugce Toprak; James Bewes; Ozkan Doganay
Journal:  J Clin Imaging Sci       Date:  2022-02-19

4.  Peripheral blood leucocyte telomere length is associated with progression of interstitial lung disease in systemic sclerosis.

Authors:  Shuo Liu; Melody P Chung; Brett Ley; Sarah French; Brett M Elicker; David F Fiorentino; Lorinda S Chung; Francesco Boin; Paul J Wolters
Journal:  Thorax       Date:  2021-07-16       Impact factor: 9.102

5.  Chest CT performance and features of COVID-19 in the region of Abu Dhabi, UAE: a single institute study.

Authors:  Ghufran Aref Saeed; Abeer Ahmed Al Helali; Asad Shah; Safaa Almazrouei; Luai A Ahmed
Journal:  Chin J Acad Radiol       Date:  2021-06-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.